Published in Infect Control Hosp Epidemiol on July 16, 2013
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis (2015) 4.07
Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance. PLoS One (2015) 1.30
The impact of central line insertion bundle on central line-associated bloodstream infection. BMC Infect Dis (2014) 1.12
Surveillance of catheter-related infections: the supplementary role of the microbiology laboratory. BMC Infect Dis (2015) 0.82
A descriptive study of nosocomial infections in an adult intensive care unit in fiji: 2011-12. J Trop Med (2014) 0.81
A project to reduce the rate of central line associated bloodstream infection in ICU patients to a target of zero. BMJ Qual Improv Rep (2016) 0.78
Reduction in central line-associated bloodstream infections in patients with burns. Infect Control Hosp Epidemiol (2014) 0.77
The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections. BMC Infect Dis (2014) 0.75
Risk factors for early onset of catheter-related bloodstream infection in an intensive care unit in China: a retrospective study. Med Sci Monit (2015) 0.75
A Central Line Care Maintenance Bundle for the Prevention of Central Line-Associated Bloodstream Infection in Non-Intensive Care Unit Settings. Infect Control Hosp Epidemiol (2016) 0.75
Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA (2007) 26.98
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol (2008) 13.49
Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep (2007) 11.94
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis (2011) 11.49
Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis (2005) 9.06
Multistate point-prevalence survey of health care-associated infections. N Engl J Med (2014) 8.78
Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 8.17
Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med (2003) 7.52
Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis (2005) 6.78
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis (2011) 6.71
Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol (2012) 6.27
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis (2010) 4.98
Health care-associated invasive MRSA infections, 2005-2008. JAMA (2010) 4.79
Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis (2005) 4.52
Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med (2012) 4.19
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003. J Clin Microbiol (2005) 3.41
Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med (2012) 3.26
Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA (2006) 3.11
Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA (2009) 3.06
Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol (2006) 2.60
Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis (2004) 2.30
Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition. Infect Control Hosp Epidemiol (2013) 2.28
Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis (2011) 2.26
Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis (2006) 2.25
Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis (2009) 2.19
Fungal infections associated with contaminated methylprednisolone in Tennessee. N Engl J Med (2012) 2.16
National Healthcare Safety Network (NHSN) Report, data summary for 2010, device-associated module. Am J Infect Control (2011) 2.12
Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med (2012) 2.12
Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol (2009) 2.06
Phylogenetic diversity and microsphere array-based genotyping of human pathogenic Fusaria, including isolates from the multistate contact lens-associated U.S. keratitis outbreaks of 2005 and 2006. J Clin Microbiol (2007) 2.02
Ebola virus disease in health care workers--Sierra Leone, 2014. MMWR Morb Mortal Wkly Rep (2014) 1.99
Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics (2006) 1.91
Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis (2012) 1.91
Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections. Clin Infect Dis (2013) 1.82
Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr Infect Dis J (2004) 1.75
Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper . Infect Control Hosp Epidemiol (2008) 1.73
National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module. Am J Infect Control (2013) 1.70
Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infect Control Hosp Epidemiol (2003) 1.69
National estimates of central line-associated bloodstream infections in critical care patients. Infect Control Hosp Epidemiol (2013) 1.69
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol (2012) 1.68
Dialysis Surveillance Report: National Healthcare Safety Network (NHSN)-data summary for 2006. Semin Dial (2008) 1.67
Improving risk-adjusted measures of surgical site infection for the national healthcare safety network. Infect Control Hosp Epidemiol (2011) 1.66
Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital. J Clin Microbiol (2004) 1.66
Trends in Candida central line-associated bloodstream infections among NICUs, 1999-2009. Pediatrics (2012) 1.66
The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States. Clin Infect Dis (2008) 1.64
National Healthcare Safety Network report, data summary for 2011, device-associated module. Am J Infect Control (2013) 1.63
Coccidioidomycosis: epidemiology. Clin Epidemiol (2013) 1.42
Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis (2002) 1.40
Paraplegia caused by invasive spinal aspergillosis. Neurology (2007) 1.39
National Healthcare Safety Network (NHSN) report, data summary for 2009, device-associated module. Am J Infect Control (2011) 1.38
Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome. Antimicrob Agents Chemother (2006) 1.37
National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. Emerg Infect Dis (2009) 1.36
Rapid assessment of Ebola infection prevention and control needs--six districts, Sierra Leone, October 2014. MMWR Morb Mortal Wkly Rep (2014) 1.30
Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am J Epidemiol (2012) 1.27
Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007-2008. Emerg Infect Dis (2010) 1.26
Preliminary laboratory report of fungal infections associated with contaminated methylprednisolone injections. J Clin Microbiol (2013) 1.25
Developing a new, national approach to surveillance for ventilator-associated events: executive summary. Chest (2013) 1.20
Management of inpatients colonized or infected with antimicrobial-resistant bacteria in hospitals in the United States. Infect Control Hosp Epidemiol (2005) 1.19
Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation. J Int Assoc Physicians AIDS Care (Chic) (2012) 1.19
Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE. J Clin Microbiol (2003) 1.17
Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases. Med Mycol (2010) 1.17
Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004. Pediatr Infect Dis J (2009) 1.16
Whole genome sequence typing to investigate the Apophysomyces outbreak following a tornado in Joplin, Missouri, 2011. PLoS One (2012) 1.16
Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis . Infect Control Hosp Epidemiol (2008) 1.16
Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection. J Clin Microbiol (2007) 1.15
Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci. Emerg Infect Dis (2002) 1.10
Cryptococcus gattii infections in multiple states outside the US Pacific Northwest. Emerg Infect Dis (2013) 1.09
Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients. Crit Care Med (2004) 1.09
Relapse of fungal meningitis associated with contaminated methylprednisolone. N Engl J Med (2013) 1.08
Fungal endophthalmitis associated with compounded products. Emerg Infect Dis (2014) 1.04
Device-associated infections among neonatal intensive care unit patients: incidence and associated pathogens reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol (2012) 1.04
The epidemiology of vancomycin-resistant Enterococcus colonization in a medical intensive care unit. Infect Control Hosp Epidemiol (2003) 1.04
Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices. Pediatrics (2006) 1.03
Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis (2013) 1.03
Candidemia in neonatal intensive care units: Barcelona, Spain. Pediatr Infect Dis J (2006) 0.99
Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998-2000. Pediatr Infect Dis J (2005) 0.97
Excess costs of hospital care associated with neonatal candidemia. Pediatr Infect Dis J (2007) 0.97
Candidemia is costly--plain and simple. Clin Infect Dis (2005) 0.97
Testing for coccidioidomycosis among patients with community-acquired pneumonia. Emerg Infect Dis (2008) 0.97
Improving surveillance definitions for ventilator-associated pneumonia in an era of public reporting and performance measurement. Clin Infect Dis (2012) 0.96
Antimicrobial proficiency testing of National Nosocomial Infections Surveillance System hospital laboratories. Infect Control Hosp Epidemiol (2003) 0.95
Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol (2014) 0.95
Trends in catheter-associated urinary tract infections in adult intensive care units-United States, 1990-2007. Infect Control Hosp Epidemiol (2011) 0.93
High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand. Clin Infect Dis (2011) 0.93
Epidemiology of community-onset candidemia in Connecticut and Maryland. Clin Infect Dis (2006) 0.93